CA-125 change over time shows promise as screening tool for early detection of ovarian cancer

Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease, according to researchers at The University of Texas MD Anderson Cancer Center.

Read the whole article on Physorg

More from Physorg